Immediate Impact
65 standout
Citing Papers
Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
2025 Standout
Dendritic cell maturation in cancer
2025 Standout
Works of L. Morales being referenced
LBA15 Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| L. Morales | 119 | 75 | 20 | 45 | 10 | 177 | |
| Erik Asmus | 93 | 27 | 26 | 36 | 9 | 168 | |
| Anna H. Wu | 66 | 81 | 4 | 44 | 7 | 272 | |
| Saranya Ravi | 70 | 72 | 9 | 56 | 11 | 280 | |
| K Gugała | 111 | 63 | 4 | 35 | 9 | 195 | |
| Lonneke W. Kessels | 120 | 16 | 4 | 66 | 12 | 178 | |
| Daliah Tsoref | 59 | 41 | 55 | 33 | 15 | 165 | |
| Rodrigo Cericatto | 76 | 36 | 9 | 42 | 13 | 188 | |
| Brenda Hermsen | 55 | 129 | 55 | 51 | 14 | 273 | |
| P.J. O'Donovan | 67 | 95 | 42 | 53 | 10 | 270 | |
| Gabriella Landi | 198 | 72 | 1 | 115 | 9 | 282 |
All Works
Loading papers...